Correlation Between Recurrence of Nephrolithiasis and Persistence of Bone Resorption in Patients with Recurrent Calcium Nephrolithiasis on Long-Term Thiazide Therapy
Hydrochlorothiazide appears to be the drug of choice in patients with recurrent Ca nephrolithiasis (RCN), even in those with no metabolic disorder (1, 2). Recent research shows evidence of a pathophysiologic role for the most active metabolite of vitamin D, 1, 25(OH)2D in the persistence of hypercalciuria in patients with RCN on thiazide therapy (3, 4).
KeywordsBone Mineral Content Primary Hyperparathyroidism Urinary Oxalate Urinary Uric Acid Hexuronic Acid
Unable to display preview. Download preview PDF.
- 3.JJ Lemann, RW Gray, and ND Adams, Vitamin D metabolism in patients with nephrolithiasis, in: “Vitamin D Basic Research and its Clinical Application,” AW Norman and K Schaefer, et al., eds., Walter de Gruyter & Co., New York (1979).Google Scholar
- 5.A Broadus, KL Insogna, R Lang, LE Mallette, et al., A consideration of the hormonal basis and phosphate leak hypothesis of absorptive hypercalciuria, J. Clin. Endocrinol. Metab. 58: (1984).Google Scholar